• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p16(INK4a)免疫化学在宫颈组织病理学和细胞学中的临床应用:近期进展更新

The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments.

作者信息

Bergeron Christine, Ronco Guglielmo, Reuschenbach Miriam, Wentzensen Nicolas, Arbyn Marc, Stoler Mark, von Knebel Doeberitz Magnus

机构信息

Laboratoire Cerba, 95066 Cergy Pontoise Cedex 9, France.

出版信息

Int J Cancer. 2015 Jun 15;136(12):2741-51. doi: 10.1002/ijc.28900. Epub 2014 May 12.

DOI:10.1002/ijc.28900
PMID:24740700
Abstract

Cervical cancer screening test performance has been hampered by either lack of sensitivity of Pap cytology or lack of specificity of Human Papillomavirus (HPV) testing. This uncertainty can lead to unnecessary referral and treatment, which is disturbing for patients and increases costs for health care providers. The identification of p16(INK4a) as a marker for neoplastic transformation of cervical squamous epithelial cells by HPVs allows the identification of HPV-transformed cells in histopathology or cytopathology specimens. Diagnostic studies have demonstrated that the use of p16(INK4a) immunohistochemistry substantially improves the reproducibility and diagnostic accuracy of histopathologic diagnoses. p16(INK4a) cytology has substantially higher sensitivity for detection of cervical precancer in comparison to conventional Pap tests. Compared to HPV DNA tests, immunochemical detection of p16(INK4a) -stained cells demonstrates a significantly improved specificity with remarkably good sensitivity. About 15 years after the initial observation that p16(INK4a) is overexpressed in HPV-transformed cells we review the accumulated clinical evidence suggesting that p16(INK4a) can serve as a useful biomarker in the routine diagnostic work up of patients with HPV infections and associated lesions of the female anogenital tract.

摘要

宫颈癌筛查测试的性能受到巴氏细胞学敏感性不足或人乳头瘤病毒(HPV)检测特异性不足的阻碍。这种不确定性可能导致不必要的转诊和治疗,这对患者来说令人不安,并增加了医疗保健提供者的成本。p16(INK4a)作为HPV导致宫颈鳞状上皮细胞肿瘤转化的标志物,使得在组织病理学或细胞病理学标本中能够识别HPV转化的细胞。诊断研究表明,使用p16(INK4a)免疫组织化学可显著提高组织病理学诊断的可重复性和诊断准确性。与传统巴氏试验相比,p16(INK4a)细胞学对宫颈上皮内瘤变的检测具有显著更高的敏感性。与HPV DNA检测相比,对p16(INK4a)染色细胞的免疫化学检测显示特异性显著提高,敏感性也非常好。在首次观察到p16(INK4a)在HPV转化细胞中过度表达约15年后,我们回顾了积累的临床证据,表明p16(INK4a)可作为一种有用的生物标志物,用于对HPV感染及女性肛门生殖道相关病变患者进行常规诊断检查。

相似文献

1
The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments.p16(INK4a)免疫化学在宫颈组织病理学和细胞学中的临床应用:近期进展更新
Int J Cancer. 2015 Jun 15;136(12):2741-51. doi: 10.1002/ijc.28900. Epub 2014 May 12.
2
Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections.宫颈癌筛查的生物标志物:p16(INK4a)在凸显 HPV 感染转化中的作用。
Expert Rev Proteomics. 2012 Apr;9(2):149-63. doi: 10.1586/epr.12.13.
3
Interpretation of p16(INK4a) /Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology.宫颈细胞学专家和非专家对p16(INK4a)/Ki-67双重免疫染色用于人乳头瘤病毒阳性女性分流的解读
Cancer Cytopathol. 2015 Apr;123(4):212-8. doi: 10.1002/cncy.21511. Epub 2014 Dec 22.
4
Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.p16INK4a 细胞学、HPV mRNA 和 HPV DNA 检测在识别异常筛查结果女性中的高级别宫颈上皮内瘤变的性能。
Gynecol Oncol. 2010 Oct;119(1):98-105. doi: 10.1016/j.ygyno.2010.06.011. Epub 2010 Jul 8.
5
Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study.液基宫颈细胞学中的免疫细胞化学:一项横断面研究后的临床应用分析
Int J Cancer. 2006 Mar 1;118(5):1254-60. doi: 10.1002/ijc.21489.
6
An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions.宫颈病变中HPV L1衣壳蛋白与p16INK4a联合表达的分析
Diagn Cytopathol. 2010 Aug;38(8):573-8. doi: 10.1002/dc.21258.
7
Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.人乳头瘤病毒(HPV)阳性宫颈癌中p16 INK4a表达上调及5' CpG岛缺乏高甲基化
BMC Cancer. 2007 Mar 14;7:47. doi: 10.1186/1471-2407-7-47.
8
Combining routine morphology, p16(INK4a) immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: a tissue microarray study using classifier performance analyses.结合常规形态学、p16(INK4a)免疫组织化学和原位杂交检测阴茎癌中的人乳头瘤病毒感染:一项使用分类器性能分析的组织芯片研究
Urol Oncol. 2014 Feb;32(2):171-7. doi: 10.1016/j.urolonc.2012.04.017. Epub 2013 Mar 14.
9
Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.液基标本(SurePath)中p16INK4A过表达作为宫颈发育异常和肿瘤形成的标志物。
Diagn Cytopathol. 2002 Dec;27(6):365-70. doi: 10.1002/dc.10205.
10
Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.p16(INK4a)/Ki67免疫细胞化学与HPV聚合酶链反应联合用于头颈部癌中HPV累及情况的无创分析
Cancer Cytopathol. 2015 Apr;123(4):219-29. doi: 10.1002/cncy.21512. Epub 2014 Dec 29.

引用本文的文献

1
Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology.意大利宫颈癌筛查指南。关于在基于风险的人乳头瘤病毒(HPV)筛查中使用生物标志物的多学会建议及分级推荐评估、制定和评价(GRADE)方法
Br J Cancer. 2025 Sep 11. doi: 10.1038/s41416-025-03161-8.
2
Comparison of ProExC and p16ink4a Biological Markers in Lesional Smears With the Immunocytochemical Method and Relationship With Human Papillomavirus in Liquid-based Cervicovaginal Specimens.采用免疫细胞化学方法比较病变涂片标本中ProExC和p16ink4a生物标志物以及与液基宫颈阴道标本中人类乳头瘤病毒的关系
J Cytol. 2024 Jan-Mar;42(1):20-26. doi: 10.4103/joc.joc_57_24. Epub 2025 Feb 11.
3
Prognostic nomograms for locally advanced cervical cancer based on the SEER database: Integrating Cox regression and competing risk analysis.
基于 SEER 数据库的局部晚期宫颈癌预后列线图:Cox 回归和竞争风险分析的整合。
Medicine (Baltimore). 2024 Nov 8;103(45):e40408. doi: 10.1097/MD.0000000000040408.
4
Extended Genotyping to Stratify the Risk of CIN2+ in Women with Persistent HPV Infection, Negative Cytology and Type 3 Transformation Zone.扩展基因分型以分层持续HPV感染、细胞学阴性及3型转化区女性发生CIN2+的风险
Cancers (Basel). 2024 May 10;16(10):1816. doi: 10.3390/cancers16101816.
5
Association between serum P16ink4A concentration and CIN and cervical cancer among women attending a cervical cancer clinic in western Uganda: A case control study.乌干达西部一家宫颈癌诊所就诊女性血清P16ink4A浓度与宫颈上皮内瘤变及宫颈癌的关联:一项病例对照研究。
Gynecol Oncol Rep. 2024 Mar 31;53:101388. doi: 10.1016/j.gore.2024.101388. eCollection 2024 Jun.
6
Performance of p16/Ki67 Immunostaining for Triage of Elderly Women with Atypical Squamous Cells of Undetermined Significance.p16/Ki67免疫染色在老年意义不明确的非典型鳞状细胞女性分流中的应用
J Clin Med. 2023 May 11;12(10):3400. doi: 10.3390/jcm12103400.
7
Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high-risk human papillomavirus-positive population.辅助使用 p16 免疫组化优化高危型人乳头瘤病毒阳性人群的 CIN 病变管理。
Acta Obstet Gynecol Scand. 2022 Nov;101(11):1328-1336. doi: 10.1111/aogs.14459. Epub 2022 Sep 30.
8
The Role of p16/Ki-67 Immunostaining, hTERC Amplification and Fibronectin in Predicting Cervical Cancer Progression: A Systematic Review.p16/Ki-67免疫染色、hTERC扩增及纤连蛋白在预测宫颈癌进展中的作用:一项系统评价
Biology (Basel). 2022 Jun 23;11(7):956. doi: 10.3390/biology11070956.
9
Accuracy of high-risk HPV DNA PCR, p16 immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer.高危型 HPV DNA PCR、p16 免疫组化或两者联合检测对 HPV 驱动型口咽癌的诊断准确性。
BMC Infect Dis. 2022 Aug 6;22(1):676. doi: 10.1186/s12879-022-07654-2.
10
Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer.预测子宫颈癌预后和治疗反应的分子标志物
Cancers (Basel). 2021 Nov 17;13(22):5748. doi: 10.3390/cancers13225748.